Delivery Order SPE2DB20D7059-SPE2DB25FQKB4
Award Date 6/18/25
Potential Completion Date 6/20/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,414.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $3,721.27. This is a firm fixed-price delivery order with an ultimate completion date of April 24, 2025, with performance to be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $3,879.44 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine 1.2 GM on August 29, 2025, with completion expected by September 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Mesalamine is a medication used to treat inflammatory bowel disease, reflecting the pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,986.08 on September 8, 2025, for the supply of Mesalamine 800 mg delayed-release tablets (180-count units). This is a firm fixed-price, non-set-aside contract with performance to be completed by September 9, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Mesalamine is a medication used to treat inflammatory bowel conditions, representing a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,083.24 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count). This is a firm fixed-price delivery order with a completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $1,132.81 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on August 6, 2025, with completion expected by August 7, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contractor will perform this order from its corporate...
- The Defense Logistics Agency awarded a $17,647.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mesalamine DR 400 mg capsules (180 count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mesalamine is a therapeutic medication used primarily to treat inflammatory bowel conditions, and this...
- The Defense Logistics Agency awarded a $1,896.65 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count package), with a completion date of July 15, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a $2,113.94 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract valued at $3,199.95. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...